D E Newby|D J Webb - JoVE Visualize

Showing results (21-30 of 348) with videos related to

Pageof 35

Sort By:

Heart (British Cardiac Society)|November 14, 1998

Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin IID E Newby, N E Goodfield, A D Flapan, et al.

British Journal of Clinical Pharmacology|May 1, 1997

Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerabilityD E Newby, D G Sciberras, C M Mendel, et al.

Thrombosis and Haemostasis|November 19, 1997

An in vivo model for the assessment of acute fibrinolytic capacity of the endotheliumD E Newby, R A Wright, C A Ludlam, et al.

Cardiovascular Research|September 7, 2000

Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in manC Labinjoh, D E Newby, P Dawson, et al.

Congestive Heart Failure (Greenwich, Conn.)|August 22, 2002

The renin angiotensin system and endothelial dysfunction in chronic heart failure: role of endogenous fibrinolysisD E Newby

Circulation|March 23, 1999

Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarctionD E Newby, R A Wright, C Labinjoh, et al.

Cardiovascular Research|August 26, 1998

The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in manD E Newby, R A Wright, P Dawson, et al.

Thrombosis and Haemostasis|August 26, 2000

Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6D E Newby, A Stewart, F N Witherow, et al.

Clinical Science (London, England : 1979)|February 15, 2001

Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregationC Labinjoh, D E Newby, I B Wilkinson, et al.

Circulation|March 14, 1998

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockadeM C Verhaar, F E Strachan, D E Newby, et al.

Pageof 35

Showing results (21-30 of 348) with videos related to

Sort By:

Pageof 35

Heart (British Cardiac Society)|November 14, 1998

Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin IID E Newby, N E Goodfield, A D Flapan, et al.

British Journal of Clinical Pharmacology|May 1, 1997

Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerabilityD E Newby, D G Sciberras, C M Mendel, et al.

Thrombosis and Haemostasis|November 19, 1997

An in vivo model for the assessment of acute fibrinolytic capacity of the endotheliumD E Newby, R A Wright, C A Ludlam, et al.

Cardiovascular Research|September 7, 2000

Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in manC Labinjoh, D E Newby, P Dawson, et al.

Congestive Heart Failure (Greenwich, Conn.)|August 22, 2002

The renin angiotensin system and endothelial dysfunction in chronic heart failure: role of endogenous fibrinolysisD E Newby

Circulation|March 23, 1999

Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarctionD E Newby, R A Wright, C Labinjoh, et al.

Cardiovascular Research|August 26, 1998

The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in manD E Newby, R A Wright, P Dawson, et al.

Thrombosis and Haemostasis|August 26, 2000

Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6D E Newby, A Stewart, F N Witherow, et al.

Clinical Science (London, England : 1979)|February 15, 2001

Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregationC Labinjoh, D E Newby, I B Wilkinson, et al.

Circulation|March 14, 1998

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockadeM C Verhaar, F E Strachan, D E Newby, et al.

Pageof 35